Published online Jan 6, 2020. doi: 10.12998/wjcc.v8.i1.217
Peer-review started: September 30, 2019
First decision: October23, 2019
Revised: November 16, 2019
Accepted: November 30, 2019
Article in press: November 30, 2019
Published online: January 6, 2020
Processing time: 99 Days and 0.5 Hours
We analyzed the main features of an infant diagnosed with temporary neonatal cyanosis in order to strengthen our understanding of the disease.
We report a patient diagnosed with temporary neonatal cyanosis. The main clinical characteristics, gene mutation and treatment are discussed and a review of related literature was conducted. The neonate aged 1 d and 5 h was admitted to hospital due to cyanosis after birth. The main clinical manifestation was cyanosis, which was not improved by auxiliary ventilation and the patient showed no obvious shortness of breath or methemoglobinemia. Gene mutation analysis showed a heterozygous c.190C>T mutation in the HBG2 gene associated with transient neonatal cyanosis, which was derived from his mother. Symptomatic supportive treatment was given for 2 mo. The neonate was discharged and gradually improved with oral administration of vitamin C and vitamin B2 for 2 wk.
There is no special treatment for temporary neonatal cyanosis caused by heterozygous mutation of the HBG2 gene.
Core tip: We report a case diagnosed with temporary neonatal cyanosis. The main characteristics of the clinical manifestations and gene mutation, and treatments were assessed and a review of the related literature was performed, which may help to improve the understanding of the disease.